nDatalyze Corp · CSE:NDAT
nDatalyze — Fact Sheet (October 2021)
4 slides from nDatalyze's fact sheet, October 2021
Slide 1: Capitalization and company overview
www.ndatalyze.com CAPITALIZATION (October, 2021) Issued & Outstanding: 36,921,425 • includes 9,075,000 - .20 cent Units - consisting of (1 share &1 warrant) sold by non-brokered private placement in March 2021. The warrants strike at $0.35 - expiring March 2022. There is a warrant exercise accelerat
Slide 2: mHealth market size and deals
mHealth market size and deals: $50B growing to $150B in 7 years. 23&me has entered a financing deal that values it at $3.5 billion. Google bought FitBit for $2.1 billion. These prices are based largely on the data these companies have. The global mHealth market size is projected to grow from $53 bil
Slide 3: MLdelic, management experience and revenue sources
MLdelic (www.mldelic.com) - a business-to-business predictive tool for the identification of probable mental illness that may be used to help determine the potential effect of entheogenics on the identified mental illnesses. For researchers, application developers, clinicians, insurance companies. R
Slide 4: Contact: Jim Durward
Medxtractor holds US and Canadian patents on its CO2 process. www.ndatalyze.com Contact: Jim Durward President (403) 689-3901 jimd@ndatalyze.com